HistoryThis section has been translated automatically.
DefinitionThis section has been translated automatically.
Up to now only rarely described (14 contributions known, but certainly more frequently occurring), autosomal dominant inherited genodermatosis with reticular hyperpigmentation of the flexures, which belongs to the spectrum of reticular pigment dermatoses. Probably acantholytic variant of M. Dowling-Degos. The eponym Galli-Galli is derived from the brothers F. and W. Galli with whom the disease was first described.
You might also be interested in
EtiopathogenesisThis section has been translated automatically.
A "loss of function mutation" in the KRT5 gene was detected (as in Dowling-Degos disease). It is suspected that this mutation leads to a loss of adhesion of the keratinocytes, possibly also to a disturbance of the melanosome distribution (see histology).
ManifestationThis section has been translated automatically.
First signs of skin symptoms between the 40th and 60th year of life.
Clinical featuresThis section has been translated automatically.
Overall rather monomorphic clinical picture with spot-like, partly also confluent, also net-like hyperpigmentations with emphasis on flexures and intertrigines. Also localized on the chin, neck or back of the neck. In addition, disseminated, lenticular, reddish-brown, scaly papules and plaques on the neck, trunk and proximal extremities have also been described. 1 case of "segmental" distribution of skin lesions has been described.
HistologyThis section has been translated automatically.
Differential diagnosisThis section has been translated automatically.
TherapyThis section has been translated automatically.
Note(s)This section has been translated automatically.
Remember! The mutation in the KRT5 gene has already been described in Dowling-Degos disease. This supports the thesis that these are different variants of the same disease. Whether other diseases from the form of reticular hyperpigmentation such as:
- Erythromelanosis follicularis faciei et colli (Kitamura disease)
- Haber syndrome
- Dyschromatosis symmetrica hereditaria (Dohi disease)
are separate entities, or variants of this mutation will be discovered in the future.
LiteratureThis section has been translated automatically.
- Arnold AW et al(2012) Type 1 segmental Galli-Galli disease resulting from a previously unreported keratin 5 mutation. J Invest Dermatol132:2100-2103
- Bardach H et al (1982) Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease? dermatologist 33: 378-383
- Braun-Falco M et al (2001) Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease? J Am Acad Dermatol 45: 760-763
Hanneken S et al (2011) Galli-Galli disease. Clinical and histopathologicalinvestigation
using a case series of 18 patients. Dermatologist 62:842-851
- Mota R et al (2010) Classical and atypical presentation of Galli-Galli disease. Dermatologist 61: 284-286
- Klingmüller G (1986) The M. Galli-Galli - an entity? Nude Dermatol 12: 41- 45
Schmieder A et al (2012) Galli-Galli disease is an acantholytic variant of Dowling-Degos disease: additional genetic evidence in a German family. J Am Acad Dermatol 66:e250-251
Outgoing links (12)Acantholysis; Acanthosis nigricans (overview); Dowling-degos disease; Dyschromatosis symmetrica hereditaria; Erythromelanosis follicularis faciei et colli; Haber syndrome; Keratosis seborrhoeic (overview); Papel; Papillomatosis confluens et reticularis; Pemphigus chronicus benignus familiaris; ... Show all
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.